|
C5ORF44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.84610000003782E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.752069999994E-05 |
| Normal-vs-Stage2 |
6.036400E-03 |
| Normal-vs-Stage3 |
1.913580E-02 |
| Normal-vs-Stage4 |
5.058600E-03 |
| Stage1-vs-Stage2 |
7.026400E-01 |
| Stage1-vs-Stage3 |
7.026600E-01 |
| Stage1-vs-Stage4 |
9.118400E-01 |
| Stage2-vs-Stage3 |
9.765600E-01 |
| Stage2-vs-Stage4 |
6.741800E-01 |
| Stage3-vs-Stage4 |
7.516200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55920000000087E-06 |
| Normal-vs-AfricanAmerican |
7.940900E-03 |
| Normal-vs-Asian |
7.392600E-01 |
| Caucasian-vs-AfricanAmerican |
2.640000E-01 |
| Caucasian-vs-Asian |
2.074400E-01 |
| AfricanAmerican-vs-Asian |
5.218200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50560000000688E-06 |
| Normal-vs-Female |
3.062600E-03 |
| Male-vs-Female |
1.987200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.411900E-04 |
| Normal-vs-Extreme_Weight |
3.72039999996243E-06 |
| Normal-vs-Obese |
5.996200E-04 |
| Normal-vs-Extreme_Obese |
4.902200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.323200E-01 |
| Normal_Weight-vs-Obese |
6.602200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.358800E-01 |
| Extreme_Weight-vs-Obese |
4.205800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.995200E-01 |
| Obese-vs-Extreme_Obese |
6.616400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.042800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.597900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.05580000001149E-06 |
| Normal-vs-Age(81-100Yrs) |
6.776400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.857000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.331000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.477200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.239370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.162200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.916200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.93000000001409E-06 |
| Normal-VS-Type2 PRCC |
2.773500E-02 |
| Normal-VS-KIRP CIMP |
2.3845999952421E-08 |
| Normal-VS-Unclassified PRCC |
3.117200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.577800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.371400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.858800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.62019999996976E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
4.549400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.11729999999699E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.57239999999792E-05 |
| Normal-vs-N1 |
4.560100E-02 |
| Normal-vs-N2 |
3.050800E-01 |
| N0-vs-N1 |
4.675000E-01 |
| N0-vs-N2 |
8.624800E-01 |
| N1-vs-N2 |
6.818800E-01 |
|
|
